Kyle Kingsley of Vireo joins us and shares the upside to giving access to Cannabis for those who really need it: “If you give this to a population of 2000 people with PTSD, what are the outcomes? I can tell you there are a lot of people who claimed benefit with cannabis in the setting of PTSD, they should have access independent of the evidence across populations. Unless we’re doing a lot of harm, that’s a different thing. In my mind, the harm just doesn’t seem to be there.”


Seth Adler: Kyle Kingsley joins us. Welcome to Cannabis Economy. I'm your host Seth Adler, download episodes on That's two n's and the word economy. A ton of direct insight on so please visit. First, a word from Bedrocan and then Kyle Kingsley.

Speaker 2: Bedrocan is a patient driven global pharmaceutical minded cannabis company. Their entire end to end process is GMP certified through Dutch and ultimately European authorities. Bedrocan is the market leader in Europe for medical cannabis and has been the sole supplier to the Dutch government for 16 years. Through the Dutch government, Bedrocan provides product to 15 countries currently.

Speaker 2: As a science based company, Bedrocan invest in clinical research. [inaudible 00:00:48] University conducted a double blind placebo controlled clinical trial on fibromyalgia with Bedrocan products which yielded promising results. They are now working on a followup to that study. Bedrocan is also working on the extent to which cannabis can reduce our reliability on opioids. Bedrocan believes that clinical research is key for the future of the company, standardized product, the industry and the patient. Visit for more information.

Seth Adler: and so here we are, Kyle, very much appreciate meeting you.

Kyle Kingsley: Thank you, this is great.

Seth Adler: Yeah. What state don't you operate in it at this point, right, Kyle Kingsley?

Kyle Kingsley: Yeah, it's been a very interesting, very quick moving several weeks here. We've finished acquisitions in Nevada and New Mexico, Arizona, and Massachusetts here in the last few weeks. And that brings us up to 10 total states that we're licensed to operate in. And there's only a handful of us, a handful of multi-state operators that operate in 10 or more states. It's a rare company.

Seth Adler: So podcast line knows no time. So past couple of weeks it, folks have now seen this news a while back. Why was now the time or how was now the time?

Kyle Kingsley: Yeah, so all of this expansion was in conjunction with us transitioning to being a public company on the CSE. The ticker is V-R-E-O. We may well be the last kind of large multi-state operator that actually gets out under the CSE. We were the only one that came out last quarter to my knowledge. And yeah, we're very excited to join the ranks of publicly traded multi-state operators from the US.

Read the full transcript:

Become a member to access to webinars, quarterly reports, contributor columns, shows, excerpts, and complete podcast transcripts

Become a Member

Already a member? Login here.